Shipped cold to your door  ·  Lyophilized vialsQuestions? WhatsApp +62 811 2120 5090
A group of middle-aged adults exercising together in a park
Wellness

FOXO4-DRI and senolytic research: helping the body clear old cells

24 August 2026

FOXO4-DRI has drawn attention in aging research because of its unusual idea: helping the body clear old cells that have stopped dividing but still occupy tissue. This field of research is called senolytics, and FOXO4-DRI is one of the peptides most often discussed in it.

What senescent cells are

Senescent cells are cells that have stopped dividing but remain in place and keep sending signals to their surroundings. Their presence is discussed in research on how cells change with age, which is why the way the body clears them is studied as well. For more context on cell metabolism and aging, read NAD+ and aging: what the research says.

How FOXO4-DRI works according to the original study

In the original study, FOXO4 is understood to help hold p53 inside the nucleus of senescent cells. FOXO4-DRI was designed to disrupt that interaction, so that p53 can leave the nucleus and the old cell goes through a natural clearing process called apoptosis. The peptide is built from D-form amino acids.

What laboratory research has observed

In the study by Baar and colleagues, laboratory research in models of both accelerated aging and natural aging linked FOXO4-DRI to restored fitness and kidney function. Another study in a natural aging model looked at senescent Leydig cells and the microenvironment of testicular tissue.

In human chondrocytes expanded in the laboratory, FOXO4-DRI lowered the level of senescence and cleared more than half of the cells at a late expansion stage. The authors recommended further research to explore this finding. Context on chondrocytes can be found in Cartalax and KLOW Blend: joints and connective tissue.

Where it sits in senolytic research

Senolytic research in general also studies small-molecule compounds such as quercetin. FOXO4-DRI stands out because it is a peptide with a specific target, the interaction between FOXO4 and p53. Research on it continues to develop. For a guide to reading product information, see the marketing authorization status of peptides in Indonesia.

Full details on FOXO4-DRI are in the Peptivia catalog. If there is anything you would like to ask before ordering, the Peptivia team is ready to help through Peptivia's official WhatsApp.

Peptides in this article

Still deciding which one fits? Tell us your goal and we will help you narrow it down.

Chat on WhatsApp